Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A

NCT02629393 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Molybdenum Cofactor Deficiency, Type A

Interventions

DRUG: ORGN001 (formerly ALXN1101)

Sponsor

Origin Biosciences